申请人:Rhone-Poulenc Sante
公开号:US05236940A1
公开(公告)日:1993-08-17
Pharmaceutical compositions are disclosed. They are useful for the treatment of medical conditions associated with the effects of glutamate, comprise as active principle, at least one compound of formula: ##STR1## or a salt thereof, in which either R.sub.1 represents polyfluoroalkoxy, 2,2,2-trifluoroethyl, pentafluoroethyl, tert-butyl, trimethylsilyl or trifluoromethylthio and R.sub.2 and R.sub.3 represent hydrogen, or R.sub.1 represents polyfluoroalkoxy, R.sub.2 represents hydrogen and R.sub.3 represents alkyl, amino, alkoxy, phenyl, phenylalkyl, dimethylamino or dialkylaminoakylthio, or R.sub.1 represents polyfluoroalkoxy, R.sub.2 represents amino and R.sub.3 represents hydrogen, with the exception of 6-trifluoromethoxy-2-benzothiazolamine.
揭示了一种药物组合物,它们对于治疗与谷氨酸效应相关的医学状况非常有用,包括至少一种化合物作为活性成分,该化合物的公式为:##STR1## 或其盐,在该公式中,R.sub.1 表示聚氟烷氧基,2,2,2-三氟乙基,五氟乙基,叔丁基,三甲基硅基或三氟甲硫基,而 R.sub.2 和 R.sub.3 表示氢,或 R.sub.1 表示聚氟烷氧基,R.sub.2 表示氢,而 R.sub.3 表示烷基,氨基,烷氧基,苯基,苯基烷基,二甲基氨基或二烷基氨基烷硫基,或 R.sub.1 表示聚氟烷氧基,R.sub.2 表示氨基,而 R.sub.3 表示氢,但不包括6-三氟甲氧基-2-苯并噻唑胺。